By Dr Sunil Badve

Book Chapters

Jefferis JM; Johnson DW; Badve S, 2023, 'Hyperuricaemia and Chronic Kidney Disease', in Management of Chronic Kidney Disease: A Clinician’s Guide, Second Edition, pp. 81 - 97, http://dx.doi.org/10.1007/978-3-031-42045-0_7

O'Shea S; Badve SV; Johnson DW, 2014, 'Erythropoiesis stimulating agent resistance', in Advances in Drug Resistance Research, pp. 120 - 135

Badve SV; Hawley CM; Johnson DW, 2013, 'How do clinical outcomes of automated peritoneal dialysis compare with those of continuous ambulatory peritoneal dialysis?', in Issues in Dialysis, pp. 85 - 102

Zirapury T; van Eps C; Hawley CM; Badve SV; Johnson DW, 2013, 'An overview of erythropoietin therapy', in Erythropoietin: Human Production, Potential Uses and Adverse Effects, pp. 31 - 53

Bose B; Badve SV; Johnson DW, 2013, 'Peritoneal transport status: A risk factor for peritoneal dialysis', in Peritoneal Dialysis: Types, Procedures and Risks Factors, pp. 69 - 94

Badve SV; Hawley CM; Johnson DW, 2012, 'How do clinical outcomes of automated peritoneal dialysis compare with those of continuous ambulatory peritoneal dialysis?', in Issues in Dialysis, pp. 85 - 102

Badve SV; Beller E; Cass A; Francis DP; Hawley C; Macdougall IC; Perkovic V; Johnson DW, 2010, 'Interventions for erythropoietin-resistant anaemia in dialysis patients', in Badve SV (ed.), , John Wiley & Sons, Ltd, http://dx.doi.org/10.1002/14651858.cd006861.pub2

Journal articles

Neuen BL; Ostrominski JW; Claggett B; Beldhuis IE; Chatur S; McCausland FR; Badve SV; Arnott C; Heerspink HJL; Jun M; Falster M; de Oliveira Costa J; Pollock C; Jardine MJ; Mahaffey KW; Perkovic V; Solomon SD; Vaduganathan M, 2024, 'Bidirectional Relationship Between Kidney Disease Progression and Cardiovascular Events in Type 2 Diabetes', Journal of the American College of Cardiology, 84, pp. 2246 - 2250, http://dx.doi.org/10.1016/j.jacc.2024.08.006

Neuen BL; Badve SV; Arnott C, 2024, 'Optimizing Clinical Outcomes Beyond Heart Failure With Intravenous Iron', Journal of the American College of Cardiology, 84, pp. 1718 - 1720, http://dx.doi.org/10.1016/j.jacc.2024.09.013

Koshino A; Heerspink HJL; Jongs N; Badve SV; Arnott C; Neal B; Jardine M; Mahaffey KW; Pollock C; Perkovic V; Hansen MK; Bakker SJL; Wada T; Neuen BL, 2024, 'Canagliflozin and iron metabolism in the CREDENCE trial.', Nephrol Dial Transplant, http://dx.doi.org/10.1093/ndt/gfae198

Junek ML; Merkel PA; Vilayur E; Wald R; Khalidi N; Jayne D; Walsh M; Paizis K; Reidlinger D; Morrish A; Badve SV; Pascoe E; Paul-Brent PA; Robison L; Valks A; Walters G; Jardine M; Milton C; Ibraham A; Siva B; Desmond M; Perkovic V; Kurtkoti J; Cass A; Summers S; Brown F; Ryan J; Kerr P; Noble E; Luxton G; Mudge DW; Hawley C; Johnson DW; Peh CA; Faull RJ; Ranganathan D; Jeffs L; Nicholls K; Hughes P; Cooper B; Boudville N; Ford S; Langham R; Blockmans D; Henckaerts L; Sprangers B; Suri R; Brachemi S; Clark W; Garg A; Carette S; Pagnoux C; Reich H; Barth D; Walsh M; Khalidi N; Cox G; Mazzetti A; Robins D; Wald R; Perl J; Pavenski K; Dacouris N; Levin A; Copland M; Fairhead T; Pannu N; Qarni MU; Habib S; Girard L; Manns B; Tesar V; Hruskova Z; Chocova Z; Povlsen J; Gregersen J; Ivarsen P; Birn H; Krarup E; Pedersen EB; Thomsen I; Bech JN; Szpirt W; Egfjord M; Mesbah R; Bataille P; Rey I; Gombert B; Chantrel F; Vanhille P; Quémeneur T; Carron PL; Zaoui P; de Moreuil C; Gosselin M; Delluc A; Hanrotel-Saliou C; Le Jeune M; Ficheux M, 2024, 'Risk of Relapse of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in a Randomized Controlled Trial of Plasma Exchange and Glucocorticoids', Arthritis and Rheumatology, 76, pp. 1431 - 1438, http://dx.doi.org/10.1002/art.42843

Neuen BL; Fletcher RA; Heath L; Perkovic A; Vaduganathan M; Badve S; Tuttle KR; Pratley R; Gerstein HC; Perkovic V; Heerspink HJL, 2024, 'Cardiovascular, Kidney and Safety Outcomes with GLP-1 Receptor Agonists Alone and in Combination with SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis.', Circulation, http://dx.doi.org/10.1161/CIRCULATIONAHA.124.071689

Toussaint ND; Badve SV, 2024, 'Normalizing serum phosphate based on association, not causation? Lessons in dialysis should have taught us not to fix what we can't prove is broken', Kidney International, 106, pp. 195 - 199, http://dx.doi.org/10.1016/j.kint.2024.05.020

Yeung WCG; Toussaint ND; Badve SV, 2024, 'Vitamin D therapy in chronic kidney disease: a critical appraisal of clinical trial evidence', Clinical Kidney Journal, 17, http://dx.doi.org/10.1093/ckj/sfae227

Collister D; Pyne L; Bhasin AA; Smyth B; Herrington W; Jardine M; Mark PB; Badve S; Rossignol P; Dember LM; Wanner C; Ezekowitz J; Devereaux PJ; Parfrey P; Gansevoort R; Walsh M, 2024, 'Heart failure events in randomized controlled trials for adults receiving maintenance dialysis: a meta-epidemiologic study.', Nephrol Dial Transplant, http://dx.doi.org/10.1093/ndt/gfae156

Fussner LA; Flores-Suárez LF; Cartin-Ceba R; Specks U; Cox PG; Jayne DRW; Merkel PA; Walsh M; Paizis K; Walters G; Jardine M; Milton C; Ibraham A; Siva B; Desmond M; Perkovic V; Kurtkoti J; Vilayur E; Cass A; Summers S; Brown F; Ryan J; Kerr P; Noble E; Luxton G; Mudge DW; Hawley C; Johnson DW; Peh CA; Faull RJ; Ranganathan D; Jeffs L; Nicholls K; Hughes P; Cooper B; Boudville N; Ford S; Langham R; Reidlinger D; Morrish A; Badve SV; Pascoe E; Paul-Brent PA; Robison L; Valks A; Blockmans D; Henckaerts L; Sprangers B; Suri R; Brachemi S; Clark W; Garg A; Carette S; Pagnoux C; Reich H; Barth D; Khalidi N; Cox G; Mazzetti A; Robins D; Wald R; Perl J; Pavenski K; Dacouris N; Levin A; Copland M; Fairhead T; Pannu N; Qarni MU; Habib S; Girard L; Manns B; Tesar V; Hruskova Z; Chocova Z; Povlsen J; Gregersen J; Ivarsen P; Birn H; Krarup E; Pedersen EB; Thomsen I; Bech JN; Szpirt W; Egfjord M; Mesbah R; Bataille P; Rey I; Chantrel F; Vanhille P; Quémeneur T; Carron PL; Zaoui P; de Moreuil C; Gosselin M; Delluc A; Hanrotel-Saliou C; Le Jeune M; Ficheux M; Aniort J, 2024, 'Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Results of an International Randomized Controlled Trial (PEXIVAS)', American Journal of Respiratory and Critical Care Medicine, 209, pp. 1141 - 1151, http://dx.doi.org/10.1164/rccm.202308-1426OC

Ha JT; Freedman SB; Kelly DM; Neuen BL; Perkovic V; Jun M; Badve SV, 2024, 'Kidney Function, Albuminuria, and Risk of Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis', American Journal of Kidney Diseases, 83, pp. 350 - 359.e1, http://dx.doi.org/10.1053/j.ajkd.2023.07.023

Koshino A; Neuen BL; Oshima M; Toyama T; Hara A; Arnott C; Neal B; Jardine M; Badve SV; Mahaffey KW; Pollock C; Hansen MK; Wada T; Heerspink HJL, 2024, 'Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients With Type 2 Diabetes and CKD: A Post Hoc Analysis of CREDENCE Trial', Kidney International Reports, 9, pp. 347 - 355, http://dx.doi.org/10.1016/j.ekir.2023.11.024

Neuen BL; Jun M; Wick J; Kotwal S; Badve SV; Jardine MJ; Gallagher M; Chalmers J; Nallaiah K; Perkovic V; Peiris D; Rodgers A; Woodward M; Ronksley PE, 2024, 'Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease: a cross-sectional observational study using routinely collected Australian primary care data', The Lancet Regional Health - Western Pacific, 43, http://dx.doi.org/10.1016/j.lanwpc.2023.100988

Jun M; Wick J; Neuen BL; Kotwal S; Badve SV; Woodward M; Chalmers J; Peiris D; Rodgers A; Nallaiah K; Jardine MJ; Perkovic V; Gallagher M; Ronksley PE, 2024, 'The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset', Kidney International Reports, 9, pp. 312 - 322, http://dx.doi.org/10.1016/j.ekir.2023.11.022

Harel Z; Smyth B; Badve SV; Blum D; Beaubien-Souligny W; Silver SA; Clark E; Suri R; Mavrakanas TA; Sasal J; Prasad B; Eikelboom J; Tennankore K; Rigatto C; Prce I; Madore F; Mac-Way F; Steele A; Zeng Y; Sholzberg M; Dorian P; Yan AT; Sood MM; Gladstone DJ; Tseng E; Kitchlu A; Walsh M; Sapir D; Oliver MJ; Krishnan M; Kiaii M; Wong N; Kotwal S; Batisstella M; Acedillo R; Lok C; Weir M; Wald R, 2024, 'Anticoagulation for Patients with Atrial Fibrillation Receiving Dialysis', Journal of the American Society of Nephrology, http://dx.doi.org/10.1681/ASN.0000000000000495

Yeung WCG; Toussaint ND; Lioufas N; Hawley CM; Pascoe EM; Elder GJ; Valks A; Badve SV, 2024, 'Vitamin D status and intermediate vascular and bone outcomes in chronic kidney disease: a secondary post hoc analysis of IMPROVE-CKD', Internal Medicine Journal, http://dx.doi.org/10.1111/imj.16516

Ketema DB; Wallace H; Neuen BL; Kotwal SS; Ronksley PE; Badve S; Perkovic V; Gallagher MP; Joshi R; Jun M, 2024, 'Assessing the Quality of Care for People with CKD: A Systematic Review and Meta-Analysis', Journal of the American Society of Nephrology, 35, http://dx.doi.org/10.1681/asn.2024bzcfkb63

Ha JT; Hiremath S; Jun M; Green SC; Wheeler DC; Coyne DW; Perkovic V; Badve SV, 2024, 'Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Kidney Disease.', NEJM Evid, 3, pp. EVIDoa2300189, http://dx.doi.org/10.1056/EVIDoa2300189

Ha J; Hiremath S; Jun M; Palmer S; Wheeler D; Coyne D; Perkovic V; Badve S, 2024, 'WCN24-2313 LONG-TERM SAFETY OF HYPOXIA-INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITORS IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED TRIALS', Kidney International Reports, 9, pp. S562 - S563, http://dx.doi.org/10.1016/j.ekir.2024.02.1183

Bose B; Milanzi E; Pascoe EM; Johnson DW; Badve SV, 2023, 'The outcomes of patients with kidney failure due to focal segmental glomerulosclerosis (FSGS) in Australia and New Zealand: A cohort study using the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA)', PLoS ONE, 18, http://dx.doi.org/10.1371/journal.pone.0293721

Yeung WCG; Palmer SC; Strippoli GFM; Talbot B; Shah N; Hawley CM; Toussaint ND; Badve SV, 2023, 'Vitamin D Therapy in Adults With CKD: A Systematic Review and Meta-analysis', American Journal of Kidney Diseases, 82, pp. 543 - 558, http://dx.doi.org/10.1053/j.ajkd.2023.04.003

Jun M; Scaria A; Andrade J; Badve SV; Birks P; Bota SE; Campain A; Djurdjev O; Garg AX; Ha J; Harel Z; Hemmelgarn B; Hockham C; James MT; Jardine MJ; Levin A; Mcarthur E; Ravani P; Shao S; Sood MM; Tan Z; Tangri N; Whitlock R; Gallagher M, 2023, 'Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational study', European Heart Journal - Quality of Care and Clinical Outcomes, 9, pp. 621 - 631, http://dx.doi.org/10.1093/ehjqcco/qcac069

Amin S; Sangadi I; Allman-Farinelli M; Badve SV; Boudville N; Coolican H; Coulshed S; Foster S; Fernando M; Haloob I; Harris DCH; Hawley CM; Holt J; Howell M; Kumar K; Johnson DW; Lee VW; Mai J; Rangan A; Roger SD; Sud K; Torres V; Vilayur E; Rangan GK, 2023, 'Participant Perceptions in a Long-term Clinical Trial of Autosomal Dominant Polycystic Kidney Disease', Kidney Medicine, 5, http://dx.doi.org/10.1016/j.xkme.2023.100691

Thomas MC; Neuen BL; Twigg SM; Cooper ME; Badve SV, 2023, 'SGLT2 inhibitors for patients with type 2 diabetes and CKD: a narrative review', Endocrine Connections, 12, http://dx.doi.org/10.1530/EC-23-0005

Inker LA; Collier W; Greene T; Miao S; Chaudhari J; Appel GB; Badve SV; Caravaca-Fontán F; Del Vecchio L; Floege J; Goicoechea M; Haaland B; Herrington WG; Imai E; Jafar TH; Lewis JB; Li PKT; Maes BD; Neuen BL; Perrone RD; Remuzzi G; Schena FP; Wanner C; Wetzels JFM; Woodward M; Heerspink HJL; Estacio RO; Hanratty R; Chalmers J; Canetta P; Barrett B; Neal B; Perkovic V; Mahaffey KW; Johnson D; Jardine M; von Eynatten M; Verde E; Verdalles U; Arroyo D; Chapman A; Torres V; Yu A; Brosnahan G; Hannedouche T; Chow KM; Szeto CC; Leung CB; Xie D; Hou FF; Dwyer J; Pohl MA; Raz I; Hunsicker LG; Vanacker A; Malfait T; Maschio G; Locatelli F; Blankestijn PJ; van Zuilen A; Kobayashi F; Makino H; Chan JCN; Andrulli S; Pozzi C; Casartelli D; Praga M; Trujillo H; Cavero T; Sevillano A; Ruggenenti P; Perna A; Carrara F; Keane WF; Manno C; Haynes R; Baigent C; Landray M; Rauen T; Seikrit C; Wied S; Toto RD; de Jong PE; Saddelli M, 2023, 'A meta-analysis of GFR slope as a surrogate endpoint for kidney failure', Nature Medicine, 29, pp. 1867 - 1876, http://dx.doi.org/10.1038/s41591-023-02418-0

Ha JT; Scaria A; Andrade J; Badve SV; Birks P; Bota SE; Campain A; Djurdjev O; Garg AX; Harel Z; Hemmelgarn B; Hockham C; James MT; Jardine MJ; Lam D; Levin A; McArthur E; Ravani P; Shao S; Sood MM; Tan Z; Tangri N; Whitlock R; Gallagher M; Jun M, 2023, 'Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and Canada', Kidney Medicine, 5, http://dx.doi.org/10.1016/j.xkme.2023.100675

Chung EYM; Badve SV; Heerspink HJL; Wong MG, 2023, 'Endothelin receptor antagonists in kidney protection for diabetic kidney disease and beyond?', Nephrology, 28, pp. 97 - 108, http://dx.doi.org/10.1111/nep.14130

Collier W; Inker LA; Haaland B; Appel GB; Badve SV; Caravaca-Fontán F; Chalmers J; Floege J; Goicoechea M; Imai E; Jafar TH; Lewis JB; Li PKT; Locatelli F; Maes BD; Neuen BL; Perrone RD; Remuzzi G; Schena FP; Wanner C; Heerspink HJL; Greene T; Estacio RO; Woodward M; Parving HH; Canetta P; Brenner BM; Barrett B; Neal B; Perkovic V; Mahaffey KW; Johnson D; Jardine M; Fervenza F; von Eynatten M; Verde E; Verdalles U; Arroyo D; Chapman A; Torres V; Yu A; Brosnahan G; Hannedouche T; Chow KM; Szeto CC; Leung CB; Xie D; Hou FF; Dwyer J; Pohl M; Raz I; Hunsicker L; Becker GJ; Katafuchi R; Vanacker A; Malfait T; Maschio G; van den Brand J; Wetzels JFM; Blankestijn P; van Zuilen A; Kobayashi F; Makino H; Chan JCN; Passerini P; Del Vecchio L; Locatelli F; Andrulli S; Pozzi C; Casartelli D; Praga M; Trujillo H; Cavero T; Sevillano A; Ruggenenti P; Perna A; Carrara F; Gherardi G; Keane WF; Manno C; Haynes R; Herrington WG; Baigent C; Landray M; Rauen T; Seikrit C; Wied S; Toto RD; de Zeeuw D; de Jong PE; Saddelli M; Zucchelli P, 2023, 'Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKD', Clinical Journal of the American Society of Nephrology, 18, pp. 183 - 192, http://dx.doi.org/10.2215/CJN.0000000000000050

Madken M; Mallick R; Rhodes E; Mahdavi R; Bader Eddeen A; Hundemer GL; Kelly DM; Karaboyas A; Robinson B; Bieber B; Molnar AO; Badve SV; Tanuseputro P; Knoll G; Sood MM, 2023, 'Development and Validation of a Predictive Risk Algorithm for Bleeding in Individuals on Long-term Hemodialysis: An International Prospective Cohort Study (BLEED-HD)', Canadian Journal of Kidney Health and Disease, 10, http://dx.doi.org/10.1177/20543581231169610

Koshino A; Neuen BL; Oshima M; Toyama T; Hara A; Arnott CG; Neal B; Jardine M; Badve S; Mahaffey KW; Pollock CA; Hansen MK; Wada T; Heerspink HJ, 2023, 'Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients with Type 2 Diabetes and CKD: A Post Hoc Analysis of the CREDENCE Trial', Journal of the American Society of Nephrology, 34, pp. 140 - 140, http://dx.doi.org/10.1681/asn.20233411s1140b

Koshino A; Neuen BL; Arnott CG; Neal B; Jardine M; Badve S; Mahaffey KW; Pollock CA; Hansen MK; Wada T; Heerspink HJ, 2023, 'Iron Biomarkers and Effects of Canagliflozin in Patients with Type 2 Diabetes and CKD: A Post Hoc Analysis of the CREDENCE Trial', Journal of the American Society of Nephrology, 34, pp. 140 - 140, http://dx.doi.org/10.1681/asn.20233411s1140c

Ha J; Hiremath S; Jun M; Palmer S; Wheeler DC; Coyne DW; Perkovic V; Badve S, 2023, 'Long-Term Safety of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in CKD: A Systematic Review and Meta-Analysis of Randomized Trials', Journal of the American Society of Nephrology, 34, pp. 367 - 367, http://dx.doi.org/10.1681/asn.20233411s1367a

Jun M; Wick J; Neuen BL; Kotwal SS; Badve S; Chalmers JP; Jardine M; Perkovic V; Gallagher MP; Ronksley PE, 2023, 'The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset', Journal of the American Society of Nephrology, 34, pp. 373 - 373, http://dx.doi.org/10.1681/asn.20233411s1373a

Hammett C; Badve SV; Kerr PG; Tran HA; Dundon BK; Lo S; Wong A; Joseph JE; Deague J; Perkovic V, 2022, 'Oral Anticoagulant Use in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Review of the Evidence With Recommendations for Australian Clinical Practice', Heart Lung and Circulation, 31, pp. 1604 - 1611, http://dx.doi.org/10.1016/j.hlc.2022.09.003

Viecelli AK; Teixeira-Pinto A; Valks A; Baer R; Cherian R; Cippà PE; Craig JC; DeSilva R; Jaure A; Johnson DW; Kiriwandeniya C; Kopperschmidt P; Liu WJ; Lee T; Lok C; Madhan K; Mallard AR; Oliver V; Polkinghorne KR; Quinn RR; Reidlinger D; Roberts M; Sautenet B; Hooi LS; Smith R; Snoeijs M; Tordoir J; Vachharajani TJ; Vanholder R; Vergara LA; Wilkie M; Yang B; Yuo TH; Zou L; Hawley CM; Robison L; Welch A; Badve SV; Boudville N; Campbell K; Cho Y; Collins M; Fahim MA; Jardine M; Du Toit D; Mayne M; Stevenson K; James R; Vu Q; Allen K; Glancy L; Kumbikkal J; Burton S; Gordon L; McCarthy K; Forrester C; Lima S; Bourgault O; Drouault C; Teasdale F; Jiun LW; Abidin J; Kiang CJ; Leng LS; Yusoff YM; Ciochina A; van Loon M; Ophelders R; Vleugels MJ; Ferrari P; Brodeur MÈ; Giunzioni D; Molfese CB; Blackwell C; Dunn L; Gillis L; Gray B; Jenkins S, 2022, 'Study protocol for Vascular Access outcome measure for function: a vaLidation study In hemoDialysis (VALID): A multi-center, multinational validation study to assess the accuracy and feasibility of measuring vascular access function in clinical practice', BMC Nephrology, 23, http://dx.doi.org/10.1186/s12882-022-02987-1

Li C; Yu J; Hockham C; Perkovic V; Neuen BL; Badve SV; Houston L; Lee VYJ; Barraclough JY; Fletcher RA; Mahaffey KW; Heerspink HJL; Cannon CP; Neal B; Arnott C, 2022, 'Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta-analysis', Diabetes, Obesity and Metabolism, 24, pp. 1927 - 1938, http://dx.doi.org/10.1111/dom.14772

Ethier I; Boudville N; McDonald S; Brown F; Kerr PG; Walker R; Holt SG; Badve SV; Cho Y; Hawley C; Robison L; Reidlinger D; Milanzi E; Bieber B; McCullough K; Johnson DW, 2022, 'Representativeness of the PDOPPS cohort compared to the Australian PD population', Peritoneal Dialysis International, 42, pp. 403 - 414, http://dx.doi.org/10.1177/08968608211056242

Hockham C; Bao L; Tiku A; Badve SV; Bello AK; Jardine MJ; Jha V; Toyama T; Woodward M; Jun M, 2022, 'Sex differences in chronic kidney disease prevalence in Asia: A systematic review and meta-analysis', Clinical Kidney Journal, 15, pp. 1144 - 1151, http://dx.doi.org/10.1093/ckj/sfac030

Davies S; Zhao J; McCullough KP; Kim YL; Wang AYM; Badve SV; Mehrotra R; Kanjanabuch T; Kawanishi H; Robinson B; Pisoni R; Perl J, 2022, 'International Icodextrin Use and Association with Peritoneal Membrane Function, Fluid Removal, Patient and Technique Survival', Kidney360, 3, pp. 872 - 882, http://dx.doi.org/10.34067/KID.0006922021

Bose B; Chung EYM; Hong R; Strippoli GFM; Johnson DW; Yang WL; Badve SV; Palmer SC, 2022, 'Immunosuppression therapy for idiopathic membranous nephropathy: systematic review with network meta-analysis', Journal of Nephrology, 35, pp. 1159 - 1170, http://dx.doi.org/10.1007/s40620-022-01268-2

Lioufas NM; Pascoe EM; Hawley CM; Elder GJ; Badve SV; Block GA; Johnson DW; Toussaint ND, 2022, 'Systematic Review and Meta-Analyses of the Effects of Phosphate-Lowering Agents in Nondialysis CKD', Journal of the American Society of Nephrology, 33, pp. 59 - 76, http://dx.doi.org/10.1681/ASN.2021040554

Bose B; Badve SV; Johnson DW; Hawley C; Jha V; Reidlinger D; Peh CA, 2022, 'Treatment preferences for primary membranous nephropathy: Results of a multinational survey among nephrologists in the South Asia Pacific region', Nephrology, 27, pp. 35 - 43, http://dx.doi.org/10.1111/nep.13953

Ha J; Freedman B; Kelly DM; Neuen BL; Perkovic V; Jun M; Badve S, 2022, 'Lower Glomerular Filtration Rate and Higher Albuminuria Are Associated With Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis', Journal of the American Society of Nephrology, 33, pp. 297 - 298, http://dx.doi.org/10.1681/asn.20223311s1297c

Rangan GK; Wong ATY; Munt A; Zhang JQJ; Saravanabavan S; Louw S; Allman-Farinelli M; Badve SV; Boudville N; Chan J; Coolican H; Coulshed S; Edwards ME; Erickson BJ; Fernando M; Foster S; Gregory AV; Haloob I; Hawley CM; Holt J; Howard K; Howell M; Johnson DW; Kline TL; Kumar K; Lee VW; Lonergan M; Mai J; McCloud P; Pascoe E; Peduto A; Rangan A; Roger SD; Sherfan J; Sud K; Torres VE; Vilayur E; Harris DCH, 2022, 'Prescribed Water Intake in Autosomal Dominant Polycystic Kidney Disease.', NEJM Evid, 1, pp. EVIDoa2100021, http://dx.doi.org/10.1056/EVIDoa2100021

Back to profile page